HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 281 filers reported holding HAEMONETICS CORP in Q4 2018. The put-call ratio across all filers is 2.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,881,539 | +6.9% | 21,004 | +1.6% | 0.67% | +8.0% |
| Q2 2023 | $1,760,525 | +4.7% | 20,678 | +1.8% | 0.62% | -5.5% |
| Q1 2023 | $1,681,563 | -20.1% | 20,321 | -24.1% | 0.66% | -32.0% |
| Q4 2022 | $2,105,696 | +9.6% | 26,773 | +3.2% | 0.97% | +2.9% |
| Q3 2022 | $1,921,000 | +287.3% | 25,943 | +421.8% | 0.94% | +128.0% |
| Q1 2020 | $496,000 | -0.6% | 4,972 | +14.6% | 0.41% | +14.7% |
| Q4 2019 | $499,000 | +1.2% | 4,340 | +10.9% | 0.36% | -14.0% |
| Q3 2019 | $493,000 | +11.5% | 3,912 | +6.4% | 0.42% | +32.1% |
| Q2 2019 | $442,000 | +68.1% | 3,677 | +22.2% | 0.32% | +56.7% |
| Q1 2019 | $263,000 | +4.0% | 3,010 | +19.2% | 0.20% | -11.7% |
| Q4 2018 | $253,000 | -10.0% | 2,525 | +3.0% | 0.23% | +9.0% |
| Q3 2018 | $281,000 | +25.4% | 2,452 | -1.7% | 0.21% | +15.3% |
| Q2 2018 | $224,000 | – | 2,494 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |